Identification of genes involved in human mesothelial cancer progression using a modified differential display technique

Cancer Letters

Volumn 123, Issue 1, 1998, Pages 7-14

  Frank, Sabine ^a   Von Specht, Bernd Ulrich ^a   Farthmann, Eduard Heinrich ^a   Hirsch, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Genes; Human mesothelial cancer progression; Modified differential display technique

Indexed keywords

ANTIGEN; MESSENGER RNA; RAB PROTEIN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; METASTASIS; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; RNA FINGERPRINTING; SEQUENCE HOMOLOGY; SEQUENCE TAGGED SITE;

BASE SEQUENCE; BIOLOGICAL MARKERS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032536096     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00317-0     Document Type: Article

References (38)

1. MacDonald A.D., MacDonald J.C. Malignant mesothelioma in North America. Am. Cancer. 46:1980;1650-1656.
2. Antman K.H. Clinical presentation and natural history of benign and malignant mesothelioma. Sem. Oncol. 8:1981;313-320.
3. Selikoff I.J., Hammond E.C., Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 46:1980;2736-2740.
4. Villena V., Lopez-Encuentra A., Echave-Sustaeta J., Martin-Escribano P., Ortuno-de-Solo B., Estenoz-Alfaro J. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3 and CA 19-9 assay in pleural fluid. A study of 207 patients. Cancer. 78(4):1996;736-740.
5. Taryle D.A., Lakshlyinarayan S., Sahn S.A. Pleural mesothelioma - an analysis of 18 cases and a review of the literature. Medicine. 55:1976;153-162.
6. Antman K.H. Malignant mesothelioma. N. Engl. J. Med. 303:1980;200-202.
7. Taguchi T., Ihanwar S.C., Siegfried J.M., Keller S.M., Testa J.R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q and 9p in human malignant mesothelioma. Cancer Res. 53(18):1993;4349-4355.
8. Kivipensas P., Bjorkqvist A., Karhu R., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Kallioniemi Q., Knutila S. Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet. Cytogenet. 89(1):1996;7-13.
9. Cheng J.Q., Ihanwar S.C., Klein W.M., Bell D.W., Lee W.C., Altomare D.A., Nobori T., Olopade O.I., Buckler A.J., Testa J.R. p16 alterations and deletion mapping of 9p21-p22. Cancer Res. 54(21):1994;5547-5551.
10. Metcalf R.A., Welsh J.A., Bennett W.P., Lehmann T.A., Pellin K., Linnainmaa K., Tammilehto L., Mattson K., Harris C.C. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res. 52:1992;2610-2615.
11. Nishiyama Y., Suwa H., Okamoto K., Fukumonto M., Hiai H., Toyokuni S. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn. J. Cancer Res. 86(12):1995;1150-1158.
12. Bauer D., Müller H., Reich J., Riedel H., Ahrenkiel V., Warthoe P., Strauss M. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res. 21:1993;4272-4280.
13. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
14. Liang P., Averboukh L., Keyomarsi K., Sager R., Pardee A.B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52:1992;6966-6968.
15. McClelland M., Mathieu-Daude F., Welsh J. RNA fingerprinting and differential display using arbitrarily primed PCR. Trends Genet. 11(6):1995;242-246.
16. Diachenko L.B., Ledesma J., Chenchik A.A., Siebert P.D. Combining the technique of RNA fingerprinting and differential display to obtain differentially expressed mRNA. Biochem. Biophys. Res. Commun. 219(3):1996;824-828.
17. Reale F.R., Griffin W.G., Compton J.M., Graham S., Towns P.L., Bogden A. Characterisation of a human malignant mesothelioma cell line (H-Meso-1): a biphasic solid and ascitic tumor model. Cancer Res. 47:1987;3199-3205.
18. Griffin T.W., Richardson C., Houston L.L., LePage D., Bodgen A., Raso V. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Cancer Res. 47:1987;4266-4270.
19. Stylianou E., Jenner L.A., Davies M., Coles G.A., Williams J.D. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 37:1990;1563-1570.
20. Niedbala N.J., Crickard K., Bernacki R.J. Adhesion, growth and morphology of human mesothelial cells on extracellular matrix. J. Cell Sci. 85:1986;133-147.
21. Kohrer K., Domdey H. Preparation of high molecular weight RNA. Methods Enzymol. 194:1990;398-403.
22. Li F., Barnathan E.S., Kariko K. Rapid method for screening and cloning cDNAs generated in differential mRNA display: application of northern blot for affinity capturing of cDNAs. Nucleic Acids Res. 22(9):1994;1764-1765.
23. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Biotechnology. 24:1992;104-108.
24. Law S.K.A., Micklem K.J., Shaw J.M., Zhang X.P., Dong Y., Willis A.C., Mason D.Y. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur. J. Immunol. 23:1993;2320-2325.
25. Resnick D., Freedman N., Xu S., Krieger M. Secreted extracellular domains of macrophage scavenger receptors form elongated trimers which specifically bind crocidolite asbestos. J. Biol. Chem. 268(5):1993;3538-3545.
26. Iida H., Wang L., Nishii K., Ookuma A., Shibata Y. Identification of rab12 as a secretory granule-associated small GTP-binding protein in atrial myocytes. Circ. Res. 78(2):1996;343-347.
27. Nishio Y., Aiello L.P., King G.L. Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J. 8:1994;103-106.
28. Sun Y., Hegamyer G., Colburn N.H. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res. 54:1994;1139-1144.
29. Haag E., Raman V. Effects of primer choice and source of Taq DNA polymerase on the banding patterns of differential display RT-PCR. Biotechniques. 17:1994;226-228.
30. Ito T., Kito K., Adati N., Mitsui Y., Hagiwara H., Sakaki Y. Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett. 351:1994;231-236.
31. Chen Z., Swisshelm K., Sager R. A cautionary note on reaction tubes for differential display and cDNA amplification in thermal cycling. Biotechniques. 16(6):1994;1002-1006.
32. Lohmann J., Schickle H., Bosch T. REN display, a rapid and efficient method for nonradioactive differential display and mRNA isolation. Biotechniques. 18:1995;200-202.
33. Reeves S.A., Rubio M., Louis D.N. General method for PCR amplification and direct sequencing of mRNA differential display products. Biotechniques. 18(1):1995;18-20.
34. Linskens M.H.K., Feng J., Andrews W.H., Enlow B.E., Saati S.M., Tonkin L.A., Funk W.D., Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 23:1995;3244-3251.
35. Mou L., Miller H., Li J., Wang E., Chalifour L. Improvements to the differential display method for gene analysis. Biochem. Biophys. Res. Commun. 199:1994;564-569.
36. Callard D., Lescure B., Mazzolini L. A method for the elimination of false positives generated by the mRNA differential display technique. Biotechniques. 16:1994;1096-1103.
37. Salesiotis A.N., Wang C.K., Wang C.D., Burger A., Li H., Seth A. Identification of novel genes from stomach cancer cell lines by differential display. Cancer Lett. 91:1995;47-54.
38. van Groningen J.M., Bloemers H.P., Swart W.M. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res. 55:1995;6237-6243.